Proton-pump inhibitors: understanding the complications and risks.

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Proton-pump inhibitors (PPIs) are primary treatments for gastric-acid-related conditions.
• Long-term PPI use has been linked to increasing adverse events.
• PPIs induce gastric mucosal changes like polyps and hyperplasia.

Purpose of the Study:

• To review the evidence linking long-term PPI use to adverse events.
• To evaluate the causality of reported PPI-associated complications.
• To guide appropriate PPI therapy and monitoring.

Main Methods:

• Literature review of studies on PPIs and associated risks.
• Analysis of evidence for causal relationships.
• Discussion of confounding factors and mechanisms.

Main Results:

• Most reported associations between PPIs and severe adverse events lack sufficient evidence.
• Confounding factors and lack of plausible mechanisms hinder proof of causality.
• Helicobacter pylori infection may exacerbate PPI-induced changes.

Conclusions:

• Causal relationships for most PPI-associated risks remain unproven.
• Physicians should consider appropriate PPI dosing, duration, and monitoring.
• Patient anxiety should be managed by informed clinical judgment and individualized care plans.